CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test
CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its expertise in the areas of in-vitro diagnostics (IVDs) and medical devices,proudly announced today that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the QuickFinder™ COVID-19/Flu Antigen Self-Test (Self Test) and QuickFinder™ COVID-19/Flu Antigen Pro Test (Pro Test). CovarsaDx, on behalf of test […]